nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0663	0.0663	CcSEcCtD
Lercanidipine—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.0251	0.0251	CcSEcCtD
Lercanidipine—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0244	0.0244	CcSEcCtD
Lercanidipine—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.021	0.021	CcSEcCtD
Lercanidipine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0188	CcSEcCtD
Lercanidipine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0186	0.0186	CcSEcCtD
Lercanidipine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0184	CcSEcCtD
Lercanidipine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0183	CcSEcCtD
Lercanidipine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0173	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0159	CcSEcCtD
Lercanidipine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0147	CcSEcCtD
Lercanidipine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0144	CcSEcCtD
Lercanidipine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0143	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Lercanidipine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0129	CcSEcCtD
Lercanidipine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0129	CcSEcCtD
Lercanidipine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0126	CcSEcCtD
Lercanidipine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Lercanidipine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0121	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Lercanidipine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Lercanidipine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Lercanidipine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0109	CcSEcCtD
Lercanidipine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Lercanidipine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Lercanidipine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Lercanidipine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Lercanidipine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Lercanidipine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00991	0.00991	CcSEcCtD
Lercanidipine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00954	0.00954	CcSEcCtD
Lercanidipine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00949	0.00949	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00949	0.00949	CcSEcCtD
Lercanidipine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00943	0.00943	CcSEcCtD
Lercanidipine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00943	0.00943	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00915	0.00915	CcSEcCtD
Lercanidipine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00903	0.00903	CcSEcCtD
Lercanidipine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00871	0.00871	CcSEcCtD
Lercanidipine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00869	0.00869	CcSEcCtD
Lercanidipine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00858	0.00858	CcSEcCtD
Lercanidipine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00856	0.00856	CcSEcCtD
Lercanidipine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00854	CcSEcCtD
Lercanidipine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00852	0.00852	CcSEcCtD
Lercanidipine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00821	0.00821	CcSEcCtD
Lercanidipine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00812	0.00812	CcSEcCtD
Lercanidipine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00806	0.00806	CcSEcCtD
Lercanidipine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00788	0.00788	CcSEcCtD
Lercanidipine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00785	0.00785	CcSEcCtD
Lercanidipine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00783	0.00783	CcSEcCtD
Lercanidipine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00768	0.00768	CcSEcCtD
Lercanidipine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00761	0.00761	CcSEcCtD
Lercanidipine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00756	0.00756	CcSEcCtD
Lercanidipine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00742	0.00742	CcSEcCtD
Lercanidipine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00741	CcSEcCtD
Lercanidipine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00734	0.00734	CcSEcCtD
Lercanidipine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00727	CcSEcCtD
Lercanidipine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00702	0.00702	CcSEcCtD
Lercanidipine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00699	0.00699	CcSEcCtD
Lercanidipine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00691	0.00691	CcSEcCtD
Lercanidipine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00682	0.00682	CcSEcCtD
Lercanidipine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00679	CcSEcCtD
Lercanidipine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00678	0.00678	CcSEcCtD
Lercanidipine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00668	CcSEcCtD
Lercanidipine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00665	0.00665	CcSEcCtD
Lercanidipine—Cough—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0066	CcSEcCtD
Lercanidipine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00644	CcSEcCtD
Lercanidipine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00644	CcSEcCtD
Lercanidipine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00644	CcSEcCtD
Lercanidipine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00642	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00639	0.00639	CcSEcCtD
Lercanidipine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00636	0.00636	CcSEcCtD
Lercanidipine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0063	0.0063	CcSEcCtD
Lercanidipine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00622	0.00622	CcSEcCtD
Lercanidipine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00607	CcSEcCtD
Lercanidipine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00605	CcSEcCtD
Lercanidipine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00604	CcSEcCtD
Lercanidipine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00602	CcSEcCtD
Lercanidipine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00599	0.00599	CcSEcCtD
Lercanidipine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00597	CcSEcCtD
Lercanidipine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00588	CcSEcCtD
Lercanidipine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00577	0.00577	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00562	CcSEcCtD
Lercanidipine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00558	CcSEcCtD
Lercanidipine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00554	CcSEcCtD
Lercanidipine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0055	CcSEcCtD
Lercanidipine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00549	CcSEcCtD
Lercanidipine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00543	CcSEcCtD
Lercanidipine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00536	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00533	CcSEcCtD
Lercanidipine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00532	CcSEcCtD
Lercanidipine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00528	CcSEcCtD
Lercanidipine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00509	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00505	CcSEcCtD
Lercanidipine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0049	CcSEcCtD
Lercanidipine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00488	CcSEcCtD
Lercanidipine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00488	0.00488	CcSEcCtD
Lercanidipine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00455	CcSEcCtD
Lercanidipine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00443	CcSEcCtD
Lercanidipine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00437	CcSEcCtD
Lercanidipine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00422	CcSEcCtD
Lercanidipine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00408	0.00408	CcSEcCtD
Lercanidipine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00392	CcSEcCtD
Lercanidipine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00389	CcSEcCtD
Lercanidipine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00389	CcSEcCtD
Lercanidipine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00387	CcSEcCtD
Lercanidipine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00367	CcSEcCtD
